Abstract
Mathematical expressions and approaches to the computation of rates and extents of drug bioavailability for implementation on analog and digital computers are derived. The equivalency of expressions derived on the basis of assuming compartment models to an approach based on using experimentally determined weighting functions is demonstrated. The relative merits of the two techniques are discussed: their application for use with temporal pharmacological data is emphasized. The applicability of the computational techniques to determining the availability of drugs at local sites of action (biophasic availability) and to computing preabsorptive drug release into the gastrointestinal contents (gastrointestinal bioavailability) is pointed out. An approach to computationally predicting in vivo blood level or pharmacological response vs. time profiles from in vitro dissolution testing results is presented and its limitations are discussed.
Similar content being viewed by others
References
V. F. Smolen. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. I. General considerations and procedures.J. Pharmacokin. Biopharm. 4:337–353 (1976).
V. F. Smolen and W. A. Weigand. Optimally predictivein vitro drug dissolution testing forin vivo bioavailability.J. Pharm. Sci (in press).
V. F. Smolen. Determination of time course onin vivo pharmacological effects fromin vitro drug release testing.J. Pharm. Sci. 60:878–882 (1971).
V. F. Smolen and R. J. Erb. The predictive conversion ofin vitro drug dissolution data intoin vivo drug response vs. time profiles exemplified for plasma levels of warfarin.J. Pharm. Sci (in review).
V. F. Smolen, P. B. Kuehn, and E. J. Williams. Idealized approach to the optimal design, development and evaluation of drug delivery systems. 11. Optimization of drug bioavailability inputs andin vitro drug bioavailability testing.Drug. Dev. Comm. 1:231–259 (1974/1975).
D. S. Riggs.Control Theory and Physiological Feedback Mechanisms, Williams and Wilkins, Baltimore, 1970, pp. 25–26.
L. Z. Benet. The use and application of deconvolution methods in pharmacokinetics. Abstracts of papers presented at the 13th National Meeting of the APhA Academy of Pharmaceutical Sciences, Chicago, November 5–9, 1972, pp. 169–171.
A. K. Jhawar, P. B. Kuehn, V. F. Smolen, and W. A. Weigand. Mathematical methods for the design and evaluation of drug delivery systems. I. A frequency response method for pharmacokinetic model identification.J. Pharmacokin. Biopharm. (in review).
A. K. Jhawar, V. F. Smolen, P. B. Kuehn, and W. A. Weigand. Mathematical methods for the design and evaluation of drug delivery systems. II. A generalized numerical deconvolution procedure for bioavailability vs. time profile computations.J. Pharmacokin. Biopharm. (in review).
C. D. McGillem and G. R. Cooper.Continuous and Discrete Signal and System Analysis, prelim, ed., Purdue University Press, Lafayette, 1973, Chap. 4.
A. Resigno and G. Segre. The precursor-product relationship,J. Theor. Biol. 1:498–513 (1961).
M. Hanano. Studies on absorption and excretion of drugs. VII. A new estimation method for the release of drugs from dosage forms and the availabilityin vivo.Chem. Pharm. Bull. 15:994–1001 (1967).
V. F. Smolen and W. A. Weigand. Drug bioavailability and pharmacokinetic analysis from pharmacological data.J. Pharmacokin. Biopharm. 1:329–336 (1973).
V. F. Smolen, E. J. Williams, and P. B. Kuehn. Bioavailability and pharmacokinetic analysis of chlorpromazine in humans and animals using pharmacological data.Can. J. Pharm. Sci. 10:95–106 (1976).
V. F. Smolen, P. B. Kuehn, and E. J. Williams. Idealized approach to the optimal design, development, and evaluation of drug delivery systems, I. Drug bioavailability input-pharmacological response relationships.Drug Dev. Comm. 1:143–172 (1974/1975).
E. R. Rodeman and J. T. P. Yao. Structural identification—Literature review, School of Civil Engineering, Purdue University, West Lafayette, Ind., 1973, NSF Technical Report No. CE-STR-73-3.
P. B. Kuehn and V. F. Smolen. Pharmacokinetics of chlorpromazine induced miotic response in rabbits.J. Pharm. Sci (in press).
V. F. Smolen, R. M. Paolino, A. K. Jhawar, and P. B. Kuehn. Pharmacological response kinetics of chlorpromazine induced rectal temperature depression in rabbits.J. Pharm. Sci (in press).
V. F. Smolen, B. D. Turrie, and W. A. Weigand. Drug input optimization time optimal control of simultaneously occurring multiple pharmacological effects and their inter-relationships.J. Pharm. Sci. 61:1941–1952 (1972).
V. F. Smolen. Applications of pharmacological method of drug absorption analysis to the study of the bioavailability characteristics of mydriatic drugs.Can. J. Pharm. Sci. 7:7–17 (1972).
M. Silverman and A. S. V. Burgen. Application of analog computer to measurement of intestinal absorption rates with tracers.J. Appl. Physiol. 16:911–913 (1961).
J. O. Osburn. Inverse simulation.Inst. Control Syst. 40:131–133 (1967).
H. Stelmach, J. R. Robinson, and S. P. Eriksen. Release of a drug from a dosage form.J. Pharm. Sci. 54:1453–1458 (1965).
J. G. Wagner and E. Nelson. Kinetic analysis of blood levels and urinary excretion in the absorptive phase after single doses of drug.J. Pharm. Sci. 53:1392–1403 (1961).
J. C. K. Loo and S. Riegelman. New methods for calculating the intrinsic absorption rate of drugs.J. Pharm. Sci. 57:918–928 (1969).
J. A. Jacquez.Compartmental Analysis in Biology and Medicine, Elsevier, New York, 1973, pp. 48–65.
V. F. Smolen, R. D. Barile, and J. G. Theophanous. The relationship between dose, effect, time, and biophasic drug levels.J. Pharm. Sci. 61:467–470 (1972).
J. A. Jacquez.Compartmental Analysis in Biology and Medicine, Elsevier, New York, 1973, pp. 110–111.
B. T. Fairchild and L. F. Krovetz. Ten circuits for differentiation on analog computers.Control Eng. 12:65–68 (1965).
J. G. Wagner, P. G. Welling, K. P. Lee, and J. F. Walker.In vivo and in vitro availability of commercial warfarin tablets.J. Pharm. Sci. 60:666–677 (1971).
Author information
Authors and Affiliations
Additional information
Research supported by Food and Drug Administration Contract No. 73-23, Alcon Laboratories, and the Purdue Biomedical Engineering Center.
Rights and permissions
About this article
Cite this article
Smolen, V.F. Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input ⇄ response relationships. Journal of Pharmacokinetics and Biopharmaceutics 4, 355–375 (1976). https://doi.org/10.1007/BF01063124
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01063124